Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M Rock

Pnd117 - Physician Reported Adherence in Ms Patients Treated With Injectable Platform Therapies Versus Delayed-Release Dimethyl Fumarate: Findings From a Real-World Cross-Sectional Study

Value in Health

English

Pnd79 - Reduced Healthcare Resource Utilisation for Patients Treated With Delayed Release Dimethyl Fumarate vs Injectable Therapies: Findings From a Real-World Cross-Sectional Study of Ms Patients

English

Related publications

A Retrospective Analysis of Real-World Discontinuation Rates With Delayed-Release Dimethyl Fumarate in Patients With Relapsing–Remitting Multiple Sclerosis

Neurology and Therapy

Neurology

2019

English

Effectiveness of Delayed-Release Dimethyl Fumarate on Patient-Reported Outcomes and Clinical Measures in Patients With Relapsing–remitting Multiple Sclerosis in a Real-World Clinical Setting: PROTEC

Multiple Sclerosis Journal - Experimental, Translational and Clinical

2019

English

Real-World Two-Year Treatment Patterns Among Patients With Psoriatic Arthritis Treated With Injectable Biologic Therapies

Current Medical Research and Opinion

Medicine

2020

English

Consensus Management of Gastrointestinal Events Associated With Delayed-Release Dimethyl Fumarate: A Delphi Study

Neurology and Therapy

Neurology

2015

English

Patient-Specific Factors Modulate Leukocyte Response in Dimethyl Fumarate Treated MS Patients

PLoS ONE

Multidisciplinary

2020

English

Pnd8 - Peginterferon Beta-1a Is Associated With Reduced Relapse Rates and Hospitalisations Due to Relapse Compared With Other First-Line Injectable Therapies for Multiple Sclerosis: Findings From a Real-World Cross-Sectional Study

English

Nursing Management of Gastrointestinal Adverse Events Associated With Delayed-Release Dimethyl Fumarate

Journal of Neuroscience Nursing

English

Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients With Relapsing Forms of Multiple Sclerosis (MANAGE)

International Journal of MS Care

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M Rock

Pnd117 - Physician Reported Adherence in Ms Patients Treated With Injectable Platform Therapies Versus Delayed-Release Dimethyl Fumarate: Findings From a Real-World Cross-Sectional Study

Pnd79 - Reduced Healthcare Resource Utilisation for Patients Treated With Delayed Release Dimethyl Fumarate vs Injectable Therapies: Findings From a Real-World Cross-Sectional Study of Ms Patients

Related publications

A Retrospective Analysis of Real-World Discontinuation Rates With Delayed-Release Dimethyl Fumarate in Patients With Relapsing–Remitting Multiple Sclerosis

Effectiveness of Delayed-Release Dimethyl Fumarate on Patient-Reported Outcomes and Clinical Measures in Patients With Relapsing–remitting Multiple Sclerosis in a Real-World Clinical Setting: PROTEC

Real-World Two-Year Treatment Patterns Among Patients With Psoriatic Arthritis Treated With Injectable Biologic Therapies

Consensus Management of Gastrointestinal Events Associated With Delayed-Release Dimethyl Fumarate: A Delphi Study

Patient-Specific Factors Modulate Leukocyte Response in Dimethyl Fumarate Treated MS Patients

Pnd8 - Peginterferon Beta-1a Is Associated With Reduced Relapse Rates and Hospitalisations Due to Relapse Compared With Other First-Line Injectable Therapies for Multiple Sclerosis: Findings From a Real-World Cross-Sectional Study

Nursing Management of Gastrointestinal Adverse Events Associated With Delayed-Release Dimethyl Fumarate

Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients With Relapsing Forms of Multiple Sclerosis (MANAGE)